Cancer Policy House Dems host “The Things We’ll Never Know: A Science Fair of Canceled Grants” July 11, 2025Vol.51 No.27By Jacquelyn Cobb
Cancer Policy In the name of “radical transparency,” FDA touts publication of 200 complete response letters July 11, 2025Vol.51 No.27By Jacquelyn Cobb
Cancer Policy HHS asks employees to report instances of “DEI policies that caused discrimination” July 11, 2025Vol.51 No.27By Sara Willa Ernst
Cancer Policy Medical, cancer groups respond to Trump’s “Big Beautiful Bill” becoming law July 11, 2025Vol.51 No.27By Jacquelyn Cobb
Cancer Policy Congress passes Trump’s megabill featuring historically steep Medicaid cuts July 03, 2025Vol.51 No.26By Claire Marie Porter
Cancer Policy Publications based on NIH-funded science must be made free immediately, HHS decrees July 03, 2025Vol.51 No.26By Claire Marie Porter
Cancer Policy NIDA director Volkow gets candid on addiction in Bhattacharya’s podcast July 03, 2025Vol.51 No.26By Claire Marie Porter
Cancer Policy Jacqueline Corrigan-Curay to retire as acting head of CDER at FDA June 27, 2025Vol.51 No.25By Claire Marie Porter
Cancer Policy RFK Jr.’s new committee votes on vaccine recommendations, despite Sen. Cassidy’s call for meeting delay June 27, 2025Vol.51 No.25By Claire Marie Porter and Jacquelyn Cobb
Cancer Policy “Forward funding” NIH budget plan would make competing for grants much harder June 20, 2025Vol.51 No.24By Claire Marie Porter
